Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Submitted by
admin
on June 12, 2010 - 10:14am
Source:
Trading Markets
News Tags:
Cellgene
Multiple Myeloma
dexamethasone
pomalidomide
lenalidomide
Headline:
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Do Not Allow Advertisers to Use My Personal information
